PRNewsWire
01 May 2026, 01:45 UTC · 23w ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SLNO
Verdict
Headline leans bearish. We score SLNO −1.00.
Score confirms the headline.
- Headline says
Leans bearish
From its wording — no explicit rating
- Expected · SLNO
−1.00strongly bearish





